Geron reported $-16375000 in Pre-Tax Profit for its fiscal quarter ending in June of 2025.


Pre Tax Profit Change Date
Amgen USD 1.57B 405M Jun/2025
Bio Techne USD -22860000 61.13M Jun/2025
Cassava Sciences USD -44220000 16.62M Jun/2025
Cytokinetics USD -134370000 27.01M Jun/2025
Exelixis USD 230.42M 24.72M Jun/2025
Genmab DKK 423M 179M Jun/2025
Geron USD -16375000 3.46M Jun/2025
Gilead Sciences USD 2.43B 780M Jun/2025
Incyte USD 558.01M 323.82M Jun/2025
MacroGenics USD -36150000 21.67M Jun/2025
Novartis USD 4.53B 124M Jun/2025